Delcath Systems, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
DCTH on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
566 Queensbury Avenue, Queensbury, New York

Insiders trading volume in the past year

Delcath Systems, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rosalind Advisors, Inc. Director $13.4 M +$2.54 M +23.4% Apr 18, 2024
Steven Salamon Director $10.2 M +$100 K +0.99% May 23, 2024
Aharon Gil Director $9.97 M +$100 K +1.01% May 23, 2024
Gerard Michel CHIEF EXECUTIVE OFFICER, Director $1.13 M +$100 K +9.72% Mar 19, 2024
Vojo Vukovic Chief Medical Officer $472 K +$269 K +132% Mar 19, 2024
David L. Hoffman Gen'l Counsel, Cco & Secy $277 K +$99.2 K +55.9% Mar 19, 2024
Sandra Pennell Svp Of Finance, Pfo And Pao $227 K +$72.9 K +47.3% Mar 19, 2024
John Purpura Chief Operating Officer $125 K +$49.9 K +66.8% Feb 8, 2023
Kevin Muir Gm Interventional Oncology $69.1 K Mar 19, 2024
John Richard Sylvester Director $31.7 K +$50.6 K May 23, 2024
Johnny John Svp Clinical Dev & Med Affairs Feb 8, 2023
Martha S. Rook Chief Operating Officer Mar 18, 2024
Christine Padula Interim Principal Accounting Officer Sep 1, 2021
Bridget Martell Director May 23, 2024
Roger G. Stoll Phd Director May 23, 2024
Elizabeth Czerepak Director May 23, 2024
Anthony Dias Vp Finance Feb 8, 2023

Recent Insider Transactions by Companies or Individuals for Delcath Systems, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership